Bausch licenses myopia control contact lens
Click Here to Manage Email Alerts
Bausch Health announced in a press release that one of its affiliates entered an exclusive licensing agreement for a myopia control contact lens developed by Australian nonprofit Brien Holden Vision Institute.
"For decades, BHVI [Brien Holden Vision Institute] has sought solutions to fulfill the unmet needs in the ophthalmic space by innovating commercially relevant technologies, including those specifically developed to help with myopia control,” Frank Back, BHVI chair, said in the release.
BHVI conducts vision research and has developed technologies for myopia, presbyopia, hyperopia and astigmatism, according to the release. Bausch Health said that it will leverage BHVI’s design with its other contact lens technologies to develop treatments that will aim to slow the progression of pediatric myopia.
"We are excited to leverage cutting-edge contact lens design technology from renowned ophthalmic research organization BHVI with our leading lens technologies so that we can research potential new treatment options for myopia, which continues to become more prevalent around the world," Bausch Health chair and CEO Joseph C. Papa, said in the release.
Collapse
Press Release
Read more about
Click Here to Manage Email Alerts